The deal combines the maker of Huggies diapers with the owner of the painkiller brand.

Kenvue’s stock, which had hit a record low in recent weeks, was headed for its best day ever, while Kimberly-Clark’s stock ...

Huggies maker Kimberly-Clark announced Monday it will buy Tylenol’s parent company Kenvue in a nearly $50 billion deal, ...

Kimberly-Clark's nearly $50 billion offer for Tylenol maker Kenvue is a risky bet that the world's biggest consumer market, ...

No deal might be the best outcome for dividend-seeking investors. It’s a story as old as time. Two Dividend Aristocrats meet, ...

Kimberly-Clark is buying the parent company of Tylenol, Kenvue, in a cash and stock deal worth about $48.7 billion. The deal ...

Investors will eye earnings, PMIs and a private-sector jobs gauge this week. Follow along for live news and analysis of the Dow, S&P 500 and Nasdaq.

Kimberly-Clark plans to acquire Kenvue in a $48.7 billion deal, aiming to boost long-term growth and synergies. Learn more ...

Kimberly Clark buy Tylenol maker Kenvue in a $48.7 billion cash-and-stock deal expected to close in late 2026.

A silky mom is a modern mother who prefers to use any available medical, technological, or scientific advances to make ...

Nvidia and other technology stocks are propping up Wall Street. The S&P 500 was virtually unchanged Monday, even though the ...

Kimberly-Clark seeks to acquire Kenvue for $48.7B at a 46% premium. While the deal looks expensive, the sector looks ripe for ...